Ex parte CHAMBERLIN et al. - Page 3




          Appeal No. 96-0009                                                           
          Application 08/104,417                                                       


          neurotransmitter is capable of binding a transporter which                   
          binds L-glutamate.                                                           
                                   THE REJECTION                                       
               Claims 1-4 and 22-24 stand rejected under 35 U.S.C. § 101               
          on the ground that the claimed invention lacks utility.                      


                                       OPINION                                         
               We have carefully considered all of the arguments                       
          advanced by appellants and the examiner and agree with                       
          appellants that the aforementioned rejection is not well                     
          founded.  This rejection therefore will be reversed.                         
               In parent Application 07/427,235, the examiner rejected                 
          claims 1-4 and 22-24 under both 35 U.S.C. § 101 (lack of                     
          utility) and 35 U.S.C. § 112, first paragraph (nonenablement)                
          (paper no. 20).  In the present application, the only                        
          rejection is under 35 U.S.C. § 101 (lack of utility).  The                   
          examiner, however, presents arguments directed toward lack of                
          enablement (answer, pages 3, 6 and 7) and appellants argue                   
          that the claimed invention is enabled (brief, pages 9-14).                   
          For this reason and because absence of utility can be the                    
          basis of a rejection under both 35 U.S.C. § 101 and 35 U.S.C.                

                                           3                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007